Full-Time

Director of Regulatory Affairs CMC

Confirmed live in the last 24 hours

BlueRock Therapeutics

BlueRock Therapeutics

201-500 employees

Develops advanced cellular therapies for diseases

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

This is a hybrid position, which implies that the candidate will need to work in-office some days.

Category
Legal
Risk & Compliance
Legal & Compliance
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

You match the following BlueRock Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Strong background in Regulatory Affairs CMC in a global pharmaceutical and/or biotechnology company with expertise in biologics
  • At least 8-10 years in Regulatory Affairs, CMC, and relevant years in a global pharmaceutical and/or biotechnology company with expertise in biologicals and/or cell and gene therapy products
  • Experience with combination products and device filing experience preferred
  • Extensive experience in preparing quality sections of regulatory filings including health Authority briefing documents, IND/CTA/IMPDs, and BLA/MAAs following eCTD format
  • Lead regulatory CMC discussions with global regulatory authorities
  • Experience in development, manufacturing and testing of cell therapeutics is highly desired
  • Experience in supporting the development and implementation of complex regulatory strategies with a proven track record of significant regulatory accomplishments
  • Ability to understand technical aspects of manufacturing and quality control assays and describe them in regulatory submissions and understand impacts on regulation
  • Strong interpersonal skills and the ability to collaborate effectively with various technical area experts
  • Excellent written and communication skills with attention to detail
  • Highly computer literate (Word, Excel PowerPoint), including formatting documents for regulatory submission
  • Ability to travel within US/Canada (and some additional, limited EU travel possible) up to 25% is required.
Responsibilities
  • Represent regulatory CMC on and/or lead matrix teams for cell and gene therapy pipeline products
  • Independently provide strategic guidance/input related to current regulatory requirements and expectations for cell and gene therapy CMC in support of clinical trial and marketing applications
  • Independently manage and prioritize multiple complex projects
  • Drive workflows related to Health Agency interactions (ie, briefing documents and responses to questions)
  • Interface with the Health Authorities for CMC submissions and CMC-related issues, with guidance and oversite from departmental head on complex topics (ie, comparability, specification changes, etc.)
  • Identify, communicate, and propose resolutions to routine and complex strategic issues
  • Interpret global regulations and guidance. Identify regulatory opportunities and risks
  • Anticipate and communicate possible regulatory paradigm shifts
  • Review and provide regulatory assessments on change controls
  • Prepare and manage CMC submissions for global markets while ensuring thoroughness, completeness, and timeliness, including creation and maintenance of strategy documents
  • Manage relationships with diverse teams in a collaborative manner
  • Utilize electronic systems for dossier creation and tracking
  • Support departmental initiatives, including special projects, budgeting, and authoring departmental documents
Desired Qualifications
  • Experience with combination products and device filing experience also preferred
BlueRock Therapeutics

BlueRock Therapeutics

View

BlueRock Therapeutics develops advanced cellular therapies using a unique cell gene platform that directs cellular differentiation and genetically engineers cells. This allows them to create new types of medicines aimed at treating diseases in neurology, cardiology, and immunology. Their products work by harnessing the potential of cells to regenerate and repair damaged tissues or systems in the body. Unlike many competitors, BlueRock focuses specifically on complex medical conditions such as neurodegenerative diseases, heart failure, and immune disorders, which sets them apart in the regenerative medicine market. The company's goal is to address these challenging health issues through extensive research and development, strategic partnerships, and by eventually commercializing their therapies after obtaining regulatory approval.

Company Stage

Acquired

Total Funding

$218.9M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

1%

2 year growth

3%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA RMAT designation for bemdaneprocel accelerates market entry for Parkinson's therapy.
  • Successful Phase I trial of bemdaneprocel boosts investor confidence and funding potential.
  • Collaboration with bit.bio enhances discovery and development of new cell therapies.

What critics are saying

  • Competition from established firms like Johnson & Johnson may overshadow BlueRock's innovations.
  • Reliance on strategic partnerships poses risks if partners shift focus or resources.
  • Regulatory hurdles could delay product launches, impacting revenue and market position.

What makes BlueRock Therapeutics unique

  • BlueRock uses iPSC technology to create novel cellular therapies for complex diseases.
  • Their strategic partnerships enhance R&D capabilities and expand therapeutic applications.
  • Focus on neurology, cardiology, and immunology addresses challenging medical conditions.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Hybrid Work Options